Antioestrogens in treatment of breast cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D004123:Dimethylamines / Q000627:therapeutic use; D004965:Estrogen Antagonists; D005260:Female; D006801:Humans; D008593:Menopause; D009256:Nafoxidine / Q000627:therapeutic use; D010647:Phenyl Ethers / Q000627:therapeutic use; D011956:Receptors, Cell Surface; D013267:Stilbenes / Q000627:therapeutic use*; D013997:Time Factors
D000970:Antineoplastic Agents; D004123:Dimethylamines; D004965:Estrogen Antagonists; D010647:Phenyl Ethers; D011956:Receptors, Cell Surface; D013267:Stilbenes; D009256:Nafoxidine